Amerisourcebergen Corp. v. Ace American Insurance

100 A.3d 283, 2014 Pa. Super. 198, 2014 Pa. Super. LEXIS 2904, 2014 WL 4495197
CourtSuperior Court of Pennsylvania
DecidedSeptember 15, 2014
Docket2545 EDA 2013
StatusPublished

This text of 100 A.3d 283 (Amerisourcebergen Corp. v. Ace American Insurance) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Amerisourcebergen Corp. v. Ace American Insurance, 100 A.3d 283, 2014 Pa. Super. 198, 2014 Pa. Super. LEXIS 2904, 2014 WL 4495197 (Pa. Ct. App. 2014).

Opinion

OPINION BY

JENKINS, J.

AmerisourceBergen Corporation, Ameri-sourceBergen Specialty Group, Integrated Nephrology Network, and ASD Healthcare (collectively “AmeriSource”) incurred attorney fees and related costs defending a False Claims Act 1 lawsuit brought in Massachusetts federal court. AmeriSource demanded that its insurer, ACE American Insurance Company (“ACE”), pay the attorney fees and costs, but ACE refused to pay on the basis of several exclusions in Amerisource’s 2009-10 policy. Ameri-Source brought an insurance coverage ac *285 tion against ACE alleging breach of contract and bad faith. On July 16, 2018, the trial court granted ACE’s motion for summary judgment.

AmeriSource filed a timely appeal to this Court. The trial court did not direct Am-eriSource to file a statement of matters complained of on appeal, opting instead to file a Pa.R.A.P. 1925(a) opinion incorporating by reference its order and opinion granting summary judgment.

We agree with the trial court that ACE properly denied coverage under exclusion L in Amerisource’s 2009-10 policy, the “prior or pending litigation” exclusion. Accordingly, we affirm.

A brief history of Amerisource’s policies with ACE and the False Claims Act lawsuit in Massachusetts provides the factual backdrop for our decision. AmeriSource is a group of businesses that provides a vast range of services to healthcare providers and pharmaceutical companies, including distribution, logistics, clinical education, and marketing 2 . Between May 2006 and May 2010, AmeriSource purchased the following professional liability insurance policies from ACE:

2006-07 — Amerisource’s primary insurance carrier was St. Paul Travelers. AmeriSource purchased an excess policy from Ace which provided $10 million in coverage over and above Amerisource’s self-insurance and St. Paul’s primary coverage of $21 million. AmeriSource calls this a “tower” of coverage in which Ace’s excess coverage was at the top of the tower 3 .
2007-08 — Ace provided primary coverage, the spot St. Paul’s held in 2006-07. This was a “replacement” policy for Ace’s 2006-07 policy, because ACE’s 2006-07 excess coverage was replaced with primary coverage in 2007-08. The terms of the 87-page 2007-08 primary policy were vastly different than the 4-page 2006-07 excess policy 4 .
2008-09 — Ace provided primary coverage. The 2008-09 policy is a “renewal” policy, since it renewed the primary coverage ACE provided in 2007-08 5 .
2009-10 — Ace provided primary coverage. This was a “renewal” policy, because it renewed the primary coverage ACE provided in 2008-09 and 2007-08 6 .

The policy year for each policy began on May 1st.

The False Claims Act (“FCA”) is a civil fraud statute that creates a right of action to recover damages and penalties, on behalf of the federal government, for false claims or statements to the government relating to government payments. Citizens have the right under the qui tam provision of the FCA, 31 U.S.C. § 3730(b), to bring “relator complaints” on behalf of the United States. The complaint must be filed in camera under seal and cannot be served on the defendant until the court so orders. Id. The federal government has the duty to examine the sealed complaint to determine if the United States will prosecute the FCA claims itself, dismiss the claims, or release them for prosecution by the relator. Only when the United States takes up a qui tam action itself or releases *286 it to the relator for prosecution does the court unseal the complaint and permit service on all defendants.

On June 5, 2006, Kassie Westmoreland filed a qui tam action in the District Court of Massachusetts against AmeriSource and another company, Amgen, under the FCA 7 . The complaint was kept under seal for three years. Westmoreland alleged that Amgen and AmeriSource conspired with medical providers to submit false Medicare claims relating to Aranesp, an anemia drug 8 .

AmeriSource claimed that it learned of the qui tam case in March 2008, when Amgen informed AmeriSource that Amgen was under federal investigation 9 . In February 2009, the Department of Justice (“DOJ”) informed AmeriSource that it was reviewing a relator’s allegations about Am-gen and AmeriSource. On February 11, 2009, the Massachusetts federal court permitted the government to place a redacted copy of the unserved qui tam complaint on the electronic docket 10 . On June 18, 2009, the DOJ issued a confidential subpoena to AmeriSource concerning the qui tam matter 11 .

On July 8, 2009, AmeriSource sent ACE formal notice of a potential claim and a copy of the redacted complaint 12 . In January 2010, AmeriSource received service of original process in the Massachusetts lawsuit 13 . On April 5, 2010, ACE denied coverage to AmeriSource under the 2009-10 primary coverage policy and refused to defend AmeriSource in the qui tam matter or pay claims expenses 14 .

In March 2011, AmeriSource filed the present insurance coverage action against ACE, which argued in its defense that exclusions L, K and Y in the 2009-10 policy barred coverage for the qui tam action. Subsequently, the trial court entered summary judgment in favor of ACE on the ground that both exclusions L (“pri- or or pending litigation”) and Y (“false, deceptive or unfair business practices”) precluded coverage.

In an appeal from an order granting summary judgment,

our scope of review ... is plenary, and our standard of review is clear: the trial court’s order will be reversed only where it is established that the court committed an error of law or abused its discretion. Summary judgment is appropriate only when the record clearly shows that there is no genuine issue of material fact and that the moving party is entitled to judgment as a matter of law. The reviewing court must view the record in the light most favorable to the nonmoving party and resolve all doubts as to the existence of a genuine issue of material fact against the moving party. Only when the facts are so clear that *287

Free access — add to your briefcase to read the full text and ask questions with AI

Related

HR Acquisition I Corp. v. Twin City Fire Insurance
547 F.3d 1309 (Eleventh Circuit, 2008)
Butterfield v. Giuntoli
670 A.2d 646 (Superior Court of Pennsylvania, 1995)
Norristown Auto. Co., Inc. v. Hand
562 A.2d 902 (Supreme Court of Pennsylvania, 1989)
Nationwide Mutual Insurance v. Nixon
682 A.2d 1310 (Superior Court of Pennsylvania, 1996)
Profit Wize Marketing v. Wiest
812 A.2d 1270 (Superior Court of Pennsylvania, 2002)
State Farm Fire & Casualty Co. v. MacDonald
850 A.2d 707 (Superior Court of Pennsylvania, 2004)
Hovis v. Sunoco, Inc.
64 A.3d 1078 (Superior Court of Pennsylvania, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
100 A.3d 283, 2014 Pa. Super. 198, 2014 Pa. Super. LEXIS 2904, 2014 WL 4495197, Counsel Stack Legal Research, https://law.counselstack.com/opinion/amerisourcebergen-corp-v-ace-american-insurance-pasuperct-2014.